Hospital Universitario "Virgen de la Arrixaca"
Murcia, 30120, Spain
NCT Number: NCT00852826
This study was intended to assess the value of a hemostatic and sealing agent, a collagen sponge coated with human coagulation factors (fibrinogen and thrombin) (TachoSil®), for decreasing occurrence of seroma after axillary lymphadenectomy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Murcia, 30120, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standard axillary lymphadenectomy
Three patches of collagen sponge coated with human coagulation factors (TachoSil®, Nycomed Pharma, AS) were perpendicularly placed at the end of lymphadenectomy on the axillary neurovascular bundle, thoracodorsal pedicle, and costal wall, covering the axillary walls
Other names: TachoSil(R), Nycomed Pharma, AS.
Hospital Universitario Virgen de la Arrixaca
Other
Value of a Hemostatic and Sealing Agent for Preventing Seroma After Axillary Lymphadenectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07681700
Drainage, Inflammation
Cairo, Egypt
View Trial DetailsNCT06314152
Chronic Pain, Disease Attributes
Nanchong, Sichuan, China
View Trial DetailsNCT03773575
Amputation, Amputation; Postoperative, Sequelae
Valhalla, New York, United States
View Trial DetailsNCT05929378
Chronic Pain, Disease Attributes
Nanchong, Sichuan, China
View Trial Details